BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 10174625)

  • 1. Complying with US and European change control requirements, Part II.
    Donawa ME
    Med Device Technol; 1997 Nov; 8(9):13-6. PubMed ID: 10174625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complying with US and European change control requirements, Part I.
    Donawa ME
    Med Device Technol; 1997 Oct; 8(8):10-3. PubMed ID: 10174270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meeting European and US requirements for design and development documentation, Part II.
    Donawa ME
    Med Device Technol; 1996 Dec; 7(10):10-5. PubMed ID: 10164052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meeting European and US requirements for design and development documentation, Part I.
    Donawa ME
    Med Device Technol; 1996 Nov; 7(9):12-5. PubMed ID: 10163673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlling the quality of raw materials.
    Donawa ME
    Med Device Technol; 1998; 9(1):12-5. PubMed ID: 10176139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complying with US and European complaint handling requirements.
    Donawa ME
    Med Device Technol; 1997 Sep; 8(7):12-5. PubMed ID: 10174197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Great regulatory expectations.
    Donawa M
    Med Device Technol; 1999 Dec; 10(10):24-7. PubMed ID: 10788264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organising European technical documentation to avoid duplication.
    Donawa M
    Med Device Technol; 2006 Apr; 17(3):29-31. PubMed ID: 16736662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. European and US quality system requirements for packaging.
    Donawa ME
    Med Device Technol; 1997 May; 8(4):12-4, 16-7. PubMed ID: 10167684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Servicing: meeting US and European quality system requirements.
    Donawa ME
    Med Device Technol; 1997 Mar; 8(2):16-8, 20, 22. PubMed ID: 10166364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding US labelling requirements.
    Donawa M
    Med Device Technol; 2005 Sep; 16(7):21-3. PubMed ID: 16259155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. US quality system requirements for software validation.
    Donawa ME
    Med Device Technol; 1998 Mar; 9(2):17-20. PubMed ID: 10186973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Working draft of the FDA GMP final rule (Part II).
    Donawa ME
    Med Device Technol; 1995 Nov; 6(9):9-12. PubMed ID: 10158131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. European legislation of biomedical technology.
    Mambretti C
    Ann Ist Super Sanita; 1995; 31(1):109-12. PubMed ID: 8546358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differing definitions of manufacturer.
    Donawa ME
    Med Device Technol; 1998; 9(6):14-7. PubMed ID: 10182120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meeting US and European supplier control requirements.
    Donawa M
    Med Device Technol; 2009; 20(3):24-7. PubMed ID: 19626952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the Safe Medical Devices Act of 1990.
    Hitchens M
    Nurs Manage; 1992 Sep; 23(9):128Q, 128T, 128X. PubMed ID: 1518606
    [No Abstract]   [Full Text] [Related]  

  • 18. Not long to go: the end of the transition period approaches.
    Cutler IR
    Med Device Technol; 1997 Nov; 8(9):28-30. PubMed ID: 10174627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Taking control: the Validation Master Plan.
    Donawa ME
    Med Device Technol; 1995 Dec; 6(10):12-4. PubMed ID: 10158118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The quality planning conundrum.
    Donawa ME
    Med Device Technol; 1999; 10(6):14-6. PubMed ID: 10623345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.